Category: Medical

  • UP makes a case for improving the healthcare system

    UP makes a case for improving the healthcare system

    Uttar Pradesh Chief Minister Yogi Adityanath highlighted India’s remarkable progress in healthcare over the past decade while inaugurating ‘Sharda Care-Health City’ in Greater Noida on Saturday. He stressed the importance of strengthening medical infrastructure and ensuring world-class healthcare is accessible to all.

    “For a civilized society, excellent health services are essential. The government is continuously working to promote investment in the health sector,” he stated, emphasizing that India has seen an extraordinary transformation in medical facilities in the last ten years.

    Adityanath pointed out the rapid expansion of premier medical institutions, noting that India had only six AIIMS hospitals in the past 70 years, whereas 22 have been established in the last decade under Prime Minister Narendra Modi’s leadership.

    Discussing Uttar Pradesh’s progress, he stated that the state had just 12 medical colleges until 2017. However, in the last eight years, 40 new medical colleges have been set up. Additionally, 37 medical colleges have been opened in the private sector, and three have been developed through the public-private partnership model in Maharajganj, Sambhal, and Shamli. Plans are also in place to establish medical colleges in Ballia and Balrampur, along with the remaining six districts of the state.

    The Chief Minister underscored the government’s commitment to providing free dialysis, CT scans, and MRI facilities in every district while ensuring an adequate number of doctors and technical staff, particularly in rural areas.

    To promote public health awareness, he mentioned that the ‘Mukhyamantri Arogya Mela’ is organized every Sunday in Uttar Pradesh, offering healthcare guidance and services to citizens. He further highlighted that the state leads in implementing the Ayushman Bharat scheme, with 10 crore people benefiting from golden health cards. Additionally, essential workers such as ASHA workers, ANMs, home guards, PRD jawans, and village watchmen will now receive health insurance coverage of ?5 lakh.

    Recognizing India’s emerging role in global healthcare, Adityanath emphasized the growing potential of medical tourism. “Health tourism is rapidly expanding, and India has the opportunity to become a global leader in this sector,” he concluded. Daijiworld

  • A federal judge stopped nationwide cuts to US health financing

    A federal judge stopped nationwide cuts to US health financing

    A federal judge on Wednesday paused cuts to health funding nationwide in response to a lawsuit filed by Oregon and 21 other states against the Trump administration. Universities and Democratic-led states warned the cuts would lead to layoffs, lab closures and a curtailment of scientific and medical studies.

    The injunction, ordered by US District Judge Angel Kelley, means the funding caps cannot be implemented while the lawsuit is ongoing. The caps would limit the reimbursement rate for indirect costs to 15%. According to the initial lawsuit, Oregon Health and Science University had an agreed upon reimbursement rate for those costs of 56%.

    The cuts would save more than $4 billion per year, the National Institutes of Health said in a post on X. The post also said that of $35 billion in grants distributed by NIH last year, $9 billion went to indirect costs.

    “This is a big win for science and public health,” Oregon Attorney General Dan Rayfield said. “The Trump administration’s cuts would have hurt research that’s vital to our future, and we’re glad the court stepped in to stop that. We will keep fighting to make sure that lifesaving and life-changing medical research and innovation aren’t held back by reckless decisions driven by politics.”

    The policy was “a unilateral change over a weekend, without regard for on-going research and clinical trials,” Kelley said.

    This created an “imminent risk of halting life-saving clinical trials, disrupting the development of innovative medical research and treatment, and shuttering of research facilities, without regard for current patient care,” she added.

    A US Justice Department lawyer during a Feb. 21 court hearing described the NIH post as a “misunderstanding of what the guidance does,” saying the money would not be saved but redirected to funding new research grants, according to Reuters.

    How much do Oregon universities get in federal medical research funding?
    OHSU received $277 million in NIH funding last year, including indirect costs, a spokesperson said. Those indirect costs went toward things like utilities and facilities.

    The University of Oregon received about $162 million in research funding from federal sources for fiscal year 2024. NIH funds made up about $56.7 million, or around 35%, of the federal funding.

    “The bottom line is that university research is absolutely critical to our society and to the economy — not for any one group but for everyone,” said Anshuman “AR” Razdan, the University of Oregon’s vice president for research and innovation.

    Oregon State University spokesperson Rob Odom said NIH is a valued research partner and any “across-the-board reduction in funding threatens research advances of the utmost importance to Oregon, the nation and the world.” Statesman Journal

  • Fixing the cybersecurity of rural hospital will require the USD 75M

    Fixing the cybersecurity of rural hospital will require the USD 75M

    It will cost upward of $75 million to address the cybersecurity needs of rural US hospitals, Microsoft reckons, as mounting closures threaten the lives of Americans.

    Hospitals are routinely targeted by cybercriminals because system availability is acutely linked to mortality rates, and rural facilities are often the least secure with 93 percent of malicious activity stemming from phishing and ransomware.

    When attacks strike, Microsoft research suggests 20 percent of hospitals experience increased patient mortality following a cyberattack, and when rural hospital numbers are declining rapidly, patient outcomes are also affected by having to travel farther to receive the required care.

    Microsoft said it would cost an estimated $30,000 to $40,000 per rural hospital to raise its security posture to basic standards. This would include implementing MFA, unified identity management, and separating user and privileged accounts so that the most common attacks could be largely mitigated.

    Of the approximately 2,100 total rural hospitals in the US, around 1,000 of these are truly independent – not part of a healthcare network that can roll out security solutions and policies across multiple facilities. These are often the least secure healthcare providers in the country and ensuring they’re protected against the most-exploited vulnerabilities would cost around $40 million to $45 million, per Microsoft’s analysis. To do the same across all 2,100, it would cost between $70 million and $75 million.

    That cost pertains only to the near-term cybersecurity issues affecting rural US hospitals, but a long-term solution would require work between security vendors, policymakers, and healthcare decision-makers, and likely a great deal more investment.

    Rick Pollack, president and CEO at the American Hospital Association, said: “Cybersecurity is a top priority for America’s hospitals and health systems. It is also a shared responsibility … It’s no secret that many rural hospitals across America are struggling as they serve as a healthcare lifeline in their communities, so keeping them safe is essential.”

    Pollack’s comments came in June 2024, at the launch of Microsoft’s Cybersecurity Program for Rural Hospitals, through which this latest report was published.

    Rural hospitals serve approximately 46 million US citizens, or about 14 percent of the country’s population. Between 2010 and 2017, they were also closing at an alarming rate of roughly one per month.

    In 2020 and 2021, 136 closed, and as of 2022, 429 were at high financial risk of shutting down too. Having fewer patients but the same high fixed costs as urban hospitals means that available funds are often tight for rural facilities, so maintaining their viability is a tall order.

    US government data shows that when rural hospitals close, patient mortality is threatened. Individuals have to travel 20 miles further for common services on average, and 40 miles further for specialized treatments, which can adversely affect patient outcomes when it comes to conditions such as heart attacks and strokes.

    With less money to spend, hospitals often have lower-skilled staff, including IT specialists. When there isn’t any money to pay top talent, or purchase the necessary security solutions, it makes for a vulnerable hospital.

    The US healthcare sector is battered by cyberattacks every year. In 2023, it was the leading sector affected by ransomware as attacks surged 130 percent, according to FBI figures.

    With the average cost of a data breach in the sector at $10.9 million, successful attacks on rural hospitals impose an unsustainable financial burden on already cash-strapped organizations.

    How to raise the alarm?
    The unfortunate truth is that more cyber calamities might be needed – as if there weren’t already enough – to force key decision-makers into enacting meaningful change.

    Professors at Lancaster University recently conducted extensive interviews with infosec veterans, who acknowledged that staff are often the weak links enabling attacks. They suggested better education could provide the impetus to implement the meaningful change the industry needs, like wider deployment of MFA, and so on.

    Generally speaking, staff are already called on to consider the consequences of a breach to their employer and their business partners elsewhere in the supply chain, but security pros believe that educating them on the wider practical effects that can arise from an attack could help improve protections.

    One interviewee recounted an experience with an attack on a major UK food supplier: “They made a massive amount of food in the UK. They weren’t very mature at the time, so it wiped them out pretty much for a couple of days. To the point if they had gone much further than the point that they did, it would have to go to a national [emergency] meeting to discuss how there’s going to be gaps on the food shelves across the UK.

    “So it’s trying to get that understanding. They never thought they were going to be sort of targeted for a cyberattack, but they were. They lost a massive amount of our operational capabilities. That is the kind of impact that it could have.”

    Stories like that, combined with the recent case of a cancer patient facing a tragic dilemma following the Qilin ransomware assault on a London hospital, should be included in awareness training, experts argue. The Register

  • ADB would lend Mizoram USD 108M for a healthcare initiative

    ADB would lend Mizoram USD 108M for a healthcare initiative

    The Mizoram government has proposed to secure a $108 million loan from the Asian Development Bank (ADB) to implement a new healthcare scheme, according to the state’s health and family welfare minister, Lalrinpuii.

    The Union Finance Ministry’s economic affairs department recommended changes to the original proposal, delaying the loan processing.

    As a result, the government submitted the revised proposal on February 25 after discussing it with ADB officials.

    Earlier, Mizoram Chief Minister Lalduhoma informed the state assembly that the government would introduce a universal healthcare scheme with health insurance coverage of up to Rs. 5 lakh per year starting in April.

    The scheme will offer cashless treatment at both state-run and private hospitals.

    The Chief Minister said that the Zoram People’s Movement (ZPM) government initially followed the Mizo National Front (MNF) government’s initiative.

    The MNF government had sought a Rs. 1,000 crore loan from ADB to fund the healthcare scheme.

    However, after the loan was not processed in time, the government decided to move forward with an alternative plan.

    “We are confident that we can implement the healthcare scheme with a Rs. 5 lakh health cover per year using our own funds, without borrowing from the ADB,” the Chief Minister stated.

    The government will implement the new scheme in April and is already negotiating with pensioners, government employees, and private hospitals to secure their support.

    It may sign a final agreement with private hospitals soon.

    Currently, the government is running the Mizoram State Health Care Scheme (MSHCS), introduced by the MNF government in 2019, which provides a health cover of up to Rs. 2 lakh per year. This scheme will end in March.

    Additionally, the Centre’s Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), which provides health coverage up to Rs. 5 lakh per year, is also operational in the state. Northeast Now

  • Karnataka spends ₹320cr to upgrade hospital infra and lower maternal mortality

    Karnataka spends ₹320cr to upgrade hospital infra and lower maternal mortality

    Chief Minister Siddaramaiah reaffirmed on Friday the Karnataka government’s commitment to eliminating preventable maternal mortality, announcing an allocation of Rs 320 crore to tackle the issue in the state.

    Presenting his 16th state budget, he outlined various health infrastructure projects set for implementation in 2025-26. A key initiative includes a first-of-its-kind policy in India aimed at preventing and treating burn injuries among women.

    The government plans to launch a mission-mode programme to minimise maternal mortality by strengthening obstetric services. Hospitals will be equipped with advanced technology to treat and prevent severe postpartum hemorrhage, while efforts to combat anemia among pregnant women will include the distribution of nutrition kits, financial incentives, and Vatsalya Kits in backward districts. MCH specialists will also be deployed in every taluka hospital through post re-deployment.

    To ensure accountability, maternal mortality cases will undergo audits by the State Technical Expert Committee, with its recommendations submitted to the State Empowered Committee for further action.

    Following public outrage over maternal deaths last year, the government has announced the construction of a 200-bed hospital in Bengaluru North Taluk at a cost of Rs 150 crore.

    Several Primary Health Centres in newly announced taluks—including Hanur, Alanavar, Annigeri, Maski, Sirivar, Kapu, Babaleshwar, Kolhar, Cheluru, and Terdal—will be upgraded to Community Health Centres. Additionally, a new CHC will be established in Ponnampet.

    Major hospital renovations have also been planned. Taluka hospitals in Maluru, Magadi, Kushalanagar, Koratagere, Jagaluru, Savanuru, Ramadurga, and Savadatti, as well as the district hospital in Davangere and Wenlock Hospital in Mangaluru, will be upgraded at a cost of Rs 650 crore. A new medical college will be set up in Puttur by upgrading the existing 100-bed taluka hospital.

    The ‘Gruha Aarogya Scheme,’ which was piloted in Kolar in 2024-25 to screen and treat six non-communicable diseases, will now be expanded across the state at a cost of Rs 100 crore.

    Further investments include a 200-bed hospital in Molakalmuru (Chitradurga district), a 400-bed hospital in Virajapete (Kodagu district), and the upgrade of the Community Health Centre in Tagaduru (Mysuru district) to a 100-bed hospital. Extensive repairs to district and taluk hospitals will be undertaken in a phased manner at a cost of Rs 183 crore.

    Under the Kalyana Karnataka Comprehensive Health Scheme, Rs 873 crore will be spent on improving health indicators and strengthening healthcare systems in the region. A cancer diagnosis unit will be set up at Bidar Government Medical College Hospital, while institutions modeled on NIMHANS will be established at Mysuru and Kalaburagi Medical Colleges, each costing Rs 100 crore.

    Additionally, a super-specialty hospital will be built under the Koppal Institute of Medical Sciences for Rs 100 crore, and a Kidwai Peripheral Cancer Treatment Unit will be set up at the Rajiv Gandhi Super Specialty Hospital in Raichur for Rs 50 crore. NDTV Profit

  • Healthcare AI in India is projected to reach USD 6.5B

    Healthcare AI in India is projected to reach USD 6.5B

    The India AI in healthcare market is experiencing remarkable growth, driven by increased government support, rising investments, rapid advancements in data analytics, and growing healthcare demands. Artificial Intelligence (AI) is revolutionizing the healthcare industry, playing a pivotal role in enhancing diagnostic accuracy, streamlining clinical workflows, and improving patient outcomes. As a result, the market is poised for exponential expansion over the next few years.

    According to Report Ocean, a leading strategic consulting and market research firm, the India AI in healthcare market was valued at USD 0.95 billion in 2023. During the forecast period from 2024 to 2030, the market is expected to grow at an impressive CAGR of 31.62%, reaching a valuation of USD 6.5 billion by 2030. This growth is fueled by the convergence of AI and healthcare, bolstered by India’s expanding healthcare infrastructure. The ability of AI to process vast amounts of medical data and provide actionable insights is crucial in addressing the country’s increasing need for preventive care and personalized treatment. Additionally, strategic collaborations with global players will further drive innovation and expedite the adoption of AI-powered solutions in the healthcare sector.

    Key growth drivers
    1. Rising demand for personalized medicine
    The increasing demand for personalized medicine is a key driver of the India AI in healthcare market. AI-driven solutions are enabling precision medicine by analyzing extensive patient data, including genetic information, lifestyle choices, and treatment responses. This allows for tailored treatment plans that improve patient outcomes while minimizing the trial-and-error approach of traditional medicine. With India’s diverse and populous healthcare landscape, AI’s ability to deliver targeted treatments is a game-changer.

    Moreover, AI-powered analytics improve clinical decision-making, enhance operational efficiencies, and reduce healthcare costs. AI applications such as predictive analytics and machine learning are already making a significant impact in fields such as oncology, cardiology, and neurology by facilitating early disease detection and personalized therapeutic interventions.

    2. Government initiatives and investments in AI healthcare
    The Indian government has been proactive in promoting AI adoption in the healthcare sector through various initiatives and investments. Programs such as the National Digital Health Mission (NDHM) and Ayushman Bharat Digital Mission (ABDM) are creating a robust digital healthcare ecosystem, paving the way for AI-driven innovations. Government-backed research and public-private partnerships are accelerating the development of AI applications, including medical imaging, robotic surgery, and virtual health assistants.

    3. Expansion of telemedicine and AI-powered diagnostics
    Telemedicine has gained significant traction in India, especially post-pandemic, leading to an increased reliance on AI-powered diagnostic tools. AI-based chatbots, virtual assistants, and automated diagnostic systems are enhancing remote patient consultations and facilitating early disease detection. Startups and established healthcare providers alike are leveraging AI to bridge the healthcare accessibility gap, especially in rural areas where specialist care is limited.

    4. Growth of AI in drug discovery and development
    AI is playing a crucial role in accelerating drug discovery and development processes, significantly reducing the time and costs associated with traditional pharmaceutical research. AI algorithms can analyze vast datasets, identify potential drug candidates, and predict their efficacy, expediting the process of bringing new treatments to market. Indian pharmaceutical companies are increasingly adopting AI-driven drug discovery models to gain a competitive edge.

    Regional insights: West India leads the AI healthcare market
    West India, with Mumbai and Maharashtra at its core, is emerging as the frontrunner in India’s AI-driven healthcare revolution. The region’s substantial investments in healthcare infrastructure and commitment to technological advancements are accelerating AI adoption. Mumbai, with its world-class medical institutions and research centers, is fostering innovation through AI-focused initiatives, including conferences and industry collaborations.

    Other emerging AI hubs, such as Delhi, Bengaluru, and Kerala, are also making significant contributions to the AI healthcare ecosystem. These cities are home to cutting-edge AI research labs, incubators, and startups that are driving advancements in AI-powered diagnostics, robotics, and digital health solutions.

    Conclusion
    The India AI in healthcare market is on a trajectory of unprecedented growth, driven by increasing demand for personalized medicine, government initiatives, advancements in AI-powered diagnostics, and the expansion of telemedicine. While challenges such as geopolitical tensions and data security concerns exist, the industry’s resilience, coupled with strategic collaborations and technological advancements, will propel AI’s transformative impact on India’s healthcare sector. By 2030, AI is set to redefine healthcare delivery in India, offering improved patient outcomes, enhanced efficiency, and a more connected healthcare ecosystem. Ocean

  • WHO claims USAID cuts harm combating against tuberculosis

    WHO claims USAID cuts harm combating against tuberculosis

    The Trump administration’s decision to pause US foreign aid would undo progress made in containing tuberculosis (TB) infections across low- and middle-income countries, putting the lives of millions at risk, the World Health Organization said on Wednesday.

    “Without immediate action, hard-won progress in the fight against TB is at risk. Our collective response must be swift, strategic, and fully resourced to protect the most vulnerable and maintain momentum toward ending TB,” said Tereza Kasaeva, director of WHO’s Global Programme on TB and Lung Health.

    Critical international aid, particularly from the US Agency for International Development (USAID), helped avert about 3.65 million deaths last year alone from the deadly disease, according to the agency.

    The US has historically contributed about one quarter of the total international donor funding for TB programs, which amounts to about $200 million to $250 million annually in bilateral funding, the WHO said.

    Additionally, the USAID has also halted all its funded trials, severely impeding progress in TB research.

    The funding disruptions put 18 of the highest TB-burden countries at risk, with the African region being the most affected followed by the South-East Asian and Western Pacific regions. These regions depend on 89% of the expected US funding for TB care, the agency said.

    The funding withdrawals are already pulling apart essential services in these countries, including testing and monitoring systems, drug supply chains and thousands of health workers facing layoffs.

    In a move that could ease concerns, the US Supreme Court on Wednesday declined to let the Trump administration withhold payment to foreign aid organizations for services already rendered to the government. Reuters

  • India & Belgium engage in boosting their medical collaboration

    India & Belgium engage in boosting their medical collaboration

    As part of the ongoing Belgian economic mission to India, a seminar titled “Innovation for a Healthier World: Uniting Strengths from India and Belgium” took place on March 5, 2025, at the Veermata Jijabai Botanical Udyan and Zoo in Mumbai.

    The event brought together leaders, researchers, and key stakeholders in the life sciences sector to explore how Belgian expertise and Indian pragmatism are converging to address global healthcare challenges.

    Belgium, particularly its Wallonia region, has long been a European hub for vaccine and biotherapeutics development, hosting leading biopharmaceutical companies, biotech startups, and research institutions.

    India, known as the “pharmacy of the world,” produces over 60% of the world’s vaccines and meets 20% of the global demand for generic medicines.

    With such complementary strengths, collaborations between the two nations can potentially drive impactful, globally scalable healthcare solutions.

    Strengthening Belgium–India partnerships in life sciences
    The seminar showcased several groundbreaking Belgium–India partnerships that are transforming healthcare innovation.

    GSK Belgium, a leader in vaccine development, has established strong partnerships with Indian companies like Bharat Biotech and Biological E. to enhance vaccine accessibility globally. These collaborations ensure a more resilient supply chain and long-term vaccine availability.

    Belgian biotech pioneers Univercells and Quantoom Biosciences have joined forces with the Serum Institute of India (SII) to accelerate the production of mRNA-based cancer therapies.

    This partnership is focused on reducing costs and production timelines and making advanced cancer treatments more accessible to diverse populations.

    Another key collaboration involves Sagitta Bioconcept, which has teamed up with an Indian partner to develop novel vaccines using a viral vector platform based on a deactivated measles virus.

    This joint research effort showcases how expertise from both nations can drive transformative discoveries in vaccine technology.

    Bio Sourcing, backed by the European Innovation Council Accelerator, is working with Indian companies to reduce the production costs of monoclonal antibodies, a critical component in modern biotherapeutics.

    By making these treatments more affordable and widely available, the partnership aims to enhance global healthcare accessibility.

    Based in Wallonia, the diagnostic technology firm Synabs currently produces 80% of India’s sickle cell disease detection kits and is expanding its expertise to thalassemia detection.

    With growing interest from organizations such as the Bill & Melinda Gates Foundation, this initiative could extend its benefits beyond India to African markets where these diseases are prevalent.

    In nuclear medicine, the Oncidium Foundation has partnered with the Sri Venkateswara Institute of Medical Sciences (SVIMS) in Tirupati, Andhra Pradesh, to support radioligand therapy for underserved cancer patients.

    The foundation aims to democratize access to innovative cancer treatments worldwide by leveraging advanced nuclear medicine therapies.

    Bridging Global Health Challenges Through Innovation
    From proton therapy and vaccine development to cancer treatments and ophthalmic implants, India–Belgium collaborations are paving the way for groundbreaking healthcare advancements.

    The seminar emphasized how Wallonia’s expertise in research and manufacturing—combined with India’s expansive market reach—can lead to the creation of sustainable and scalable global health solutions.

    Recent Belgian investments in India underscore the growing importance of this alliance. Quantoom Biosciences has announced plans to set up a new facility for mRNA vaccine production, further strengthening India’s role in vaccine manufacturing.

    Additionally, IBA, a Belgian company specializing in proton therapy, is supplying proton therapy units for cancer treatment, enhancing India’s capacity to provide advanced oncology care. Digital Health News

  • US hospitals are getting overcrowded

    US hospitals are getting overcrowded

    Hospitals are getting more crowded and healthcare experts are warning that has serious consequences for the quality of patient care.

    A new study published in JAMA Network projects that by 2032, national hospital occupancy rates could exceed 85%, a critical level where hospital operations may become unsafe and dysfunctional.

    This projection highlights a growing concern about the inadequate supply of hospital care to meet future demand. Although this national figure masks significant geographic and temporal variations, many areas are already experiencing a public health crisis due to hospital capacity constraints.

    Historically, hospital care has been a significant portion of healthcare spending, accounting for 29% of the estimated $1 trillion spent annually in the US From 1960 to 1982, spending on hospital-based care surged due to increased health insurance coverage, reduced cost-sharing, and technological advancements.

    In response, Medicare introduced the Inpatient Prospective Payment System in 1983, which aimed to control costs by reimbursing hospitals based on diagnoses and patient factors, rather than retrospective cost-based methods.

    Policymakers also implemented certificate of need (CON) laws to regulate the number of acute care beds, aiming to curb unnecessary hospital spending. Despite their widespread adoption, these laws have faced criticism for being ineffective and even harmful. Efforts to optimize hospital bed productivity through lean healthcare principles and just-in-time resources have inadvertently contributed to hospital consolidation and reduced acute care capacity, the study authors say.

    Pressing need for more hospital beds
    As the demand for acute care continues to grow, driven by an aging and more medically complex population, the need for greater hospital bed capacity becomes more pressing. Technological advancements have improved survival rates for serious conditions, but they have also increased the demand for hospital care.

    While some policymakers have explored alternatives like hospital-at-home programs and ambulatory care, the study said these solutions have not fully addressed the challenges of inadequate hospital capacity.

    The study concludes the US must expand hospital bed capacity, particularly for critical and complex care services. However, the current healthcare financing environment favors the rapid expansion of urgent care centers and ambulatory care, while restricting similar growth in hospital capacity.

    This selective development is based on the assumption that lower-cost settings will improve affordability and access, but the study said evidence suggests that meaningful substitution does not occur. ConsumerAffairs

  • Medical devices lay idle in storage of Delhi govt hospitals

    Medical devices lay idle in storage of Delhi govt hospitals

    Delhi chief minister Rekha Gupta on Tuesday alleged that medical equipment worth crores of rupees was lying unused in warehouses of many Delhi government-run hospitals.

    During a visit to the Guru Teg Bahadur (GTB) Hospital, Gupta said, “Since the Covid-19 pandemic, the warehouse here has been completely filled. Even today, 458 oxygen concentrators, 146 ventilators, 36,000 PPE kits, multipara monitors, masks, and other medical supplies are lying unused.”

    “This is not just the case with GTB Hospital, but with many hospitals across Delhi,” she said.

    The chief minister said that the new structures that were recently constructed at the hospitals have been constructed without proper planning. She further claimed that hospital staff had not been paid their salaries for six months.

    She added that the condition of several Delhi government hospitals was dire, with poor infrastructure. “Who is responsible for this? We will try to fix the problem,” she said.

    Hitting out at the previous government, she said, “People who are asking for the ₹2,500 (monthly aid to women) should see how the previous government has left us.”

    The CM was referring to Mahila Samriddhi Yojna — one of the key promises the Bharatiya Janata Party (BJP) made in the run-up to the Delhi Assembly elections. “AAPs health and education model is nothing but zero. Their governance is only about publicity, not real work,” she said. Hindustan Times